Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma

NCT00165217 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Adenocarcinoma

Interventions

DRUG: Capecitabine
DRUG: Thalidomide

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]